LPA and metabolic syndrome: Since individual CV risk is continuously amplified by increasing Lp(a) levels, according to the 2019 EAS/ESC guidelines on dyslipidemia management2 and expert consensus,4 individuals with very high Lp(a) levels (>320 nmol/L) should be classified as high CV risk.